Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study
- Resource Type
- Article
- Source
- In
The Lancet Rheumatology February 2022 4(2):e105-e112 - Subject
Primary Research Articles - Language
- ISSN
- 2665-9913